the Swiss HIV Cohort Study (SHCS)
Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
Scherrer A, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Calmy A, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, the Swiss HIV Cohort Study (SHCS). Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens. PloS one 2013; 8
25.07.2013Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
25.07.2013PloS one 2013; 8
Scherrer Alexandra U, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Calmy Alexandra, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, the Swiss HIV Cohort Study (SHCS)
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
Weber R, the Swiss HIV Cohort Study (SHCS), Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Tarr P, Telenti A, Trkola A, Vernazza P, Ledergerber B, Kowalska J, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, Cavassini M, Calmy A, Bernasconi E, Schmid P, Flepp M, Yerly S. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med 2012
24.09.2012Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
24.09.2012HIV Med 2012
Weber R, the Swiss HIV Cohort Study (SHCS), Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Tarr P, Telenti A, Trkola A, Vernazza Pietro, Ledergerber B, Kowalska J, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, Cavassini M, Calmy A, Bernasconi E, Schmid P, Flepp M, Yerly S
Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption
von Wyl V, Günthard H, Joos B, Weber R, Vernazza P, Hirschel B, Rauch A, Cavassini M, Bernasconi E, Battegay M, Kuster H, Niederoest B, Fischer M, Gianella S, the Swiss HIV Cohort Study (SHCS). Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption. PloS one 2011; 6:e27463.
15.11.2011Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption
15.11.2011PloS one 2011; 6:e27463
von Wyl Viktor, Günthard Huldrych F, Joos Beda, Weber Rainer, Vernazza Pietro, Hirschel Bernard, Rauch Andri, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Kuster Herbert, Niederoest Barbara, Fischer Marek, Gianella Sara, the Swiss HIV Cohort Study (SHCS)
Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
Magenta L, Bernasconi E, Bucher H, Decosterd L, Cavassini M, Evison J, Vernazza P, Hirschel B, Flepp M, Hasse B, Young J, Richter W, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS). Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy. AIDS Res Hum Retroviruses 2010
22.11.2010Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
22.11.2010AIDS Res Hum Retroviruses 2010
Magenta L, Bernasconi E, Bucher H C, Decosterd L A, Cavassini M, Evison J, Vernazza Pietro, Hirschel B, Flepp M, Hasse B, Young J, Richter W O, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS)